![]() |
市场调查报告书
商品编码
1305940
医用级有机硅市场规模 - 按形态(凝胶、橡胶、泡沫、板材、块状)、按应用(呼吸设备、医疗器械部件、植入物、骨科器械) - 全球预测(2023-2032年)Medical Grade Silicone Market Size - By Form (Gel, Rubber, Foam, Sheet, Block), By Application (Respiratory Devices, Medical Device Components, Implants, Orthopedic Forms)- Global Forecast (2023-2032) |
到2032年,全球医用级有机硅市场规模将大幅扩大。癌症、心脏病、糖尿病等慢性疾病的发病率不断上升,增加了对医疗器械的需求,从而提高了对医用级有机硅的需求。根据纽约州卫生部的数据,美国每年约有697,000人死于心脏病,每5人中就有1人死于心脏病。
此外,人们对医用级硅胶益处的认识不断提高,也将进一步促进该行业的发展。医用级硅胶的生物相容性、柔韧性、柔软性、耐用性和易消毒性使其成为广泛的医疗应用领域的重要材料。从植入物和假体到伤口敷料和医用管材,有机硅有助于提高患者的舒适度、安全性和治疗效果,从而促进行业增长。
整个医用级有机硅市场根据形态、应用和地区进行分类。
根据形态,凝胶细分市场的行业份额将在2023年至2032年期间以超过7%的复合年增长率增长。有机硅凝胶以其耐用性和使用寿命长而著称。它们具有抗降解性,可在较长时间内保持其物理性质。这种耐久性使其适合长期用于医疗设备、植入物或需要持续性能和可靠性的外部应用。此外,从用于假肢和植入物的非常柔软的凝胶到用于伤口治疗的非常粘稠的凝胶等各种质地的凝胶的高可用性也有利于其应用。
就应用领域而言,到2032年,骨科产品领域的行业价值将呈指数级增长。骨科疾病(如退行性骨病)发病率的不断增长提高了产品的采用率。根据美国疾病预防控制中心(CDC)的数据,仅在美国,约有4.2%的50岁及以上男性和18.8%的50岁及以上女性患有腰椎或股骨颈骨质疏松症。此外,骨科设备投资的增加也将进一步促进该细分市场的增长。
到2032年,欧洲医用级有机硅市场规模将超过7.5亿美元。该地区拥有瓦克化学股份公司等主要市场参与者,它们都重视产品创新。此外,心脏病、癌症等慢性疾病发病率的上升也增加了该地区对医疗器械的需求,从而刺激了对医用级有机硅的需求。
Global Medical Grade Silicone Market size will expand significantly through 2032. Surging prevalence of chronic disorders such as cancer, heart attack, diabetes, and others has increased the need for medical devices, increasing the demand for medical grade silicone. According to the New York State Department of Health, heart diseases claim around 697,000 lives in the U.S. every year, accounting for one in every five deaths.
Moreover, rising awareness of the benefits of medical grade silicone could further contribute to industry growth. Medical-grade silicone's biocompatibility, flexibility, softness, durability, and ease of sterilization make it a valuable material in a wide range of medical applications. From implants and prosthetics to wound dressings and medical tubing, silicone contributes to improved patient comfort, safety, and treatment outcomes, leading to industry growth.
The overall medical grade silicone market is categorized based on form, application, and region.
Based on form, industry share from gel segment will grow at over 7% CAGR from 2023 to 2032. Silicone gels are known for their durability and longevity. They are resistant to degradation and can maintain their physical properties over an extended period. This durability makes them suitable for long-term use in medical devices, implants, or external applications that require sustained performance and reliability. Moreover, high availability of these gels in various textures, from very soft gels used in prosthetics and implants to very sticky gels used in wound treatment, favors their adoption.
In terms of application, the industry value from the orthopedic products segment will amass exponential gains through 2032. Growing incidence of orthopedic disorders such as degenerative bone disease has increased product adoption. As per the CDC, around 4.2% of men and 18.8% of women 50 years of age and over suffer from osteoporosis of the lumbar spine or femur neck in the U.S. alone. Moreover, rising investments in orthopedic equipment will further supplement segment growth.
Europe medical grade silicone market size will be worth over USD 750 million by 2032. The region is home to major market players such as Wacker Chemie AG and others emphasizing product innovations. Moreover, the rising prevalence of chronic disorders such as heart disease, cancer, and others has increased the need for medical devices in the region, stimulating the demand for medical grade silicone.